Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Effect of Albumin Replacement on Oxygen Delivery in Sepsis Patients

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Fluid resuscitation is a critical component of sepsis treatment. Research has shown that intravenous (IV) fluid therapy in sepsis positively impacts cardiac output and thereby oxygen (O2) delivery through a complex interaction of central venous pressure, right atrial pressure, venous resistance, ventricular compliance, cardiac contractility, and systemic vascular resistance. The 2021 sepsis prevention guidelines recommend balanced crystalloids as first-line therapy. However, no studies in the literature have evaluated the effect of albumin on O2 delivery. In our study, the investigators aim to assess the impact of albumin replacement on O2 delivery in sepsis patients in the intensive care unit.

Who May Be Eligible (Plain English)

Who May Qualify: - Followed up with a diagnosis of sepsis, - over 18 years old - Patients who were diagnosed with hypo-albuminemia after more than 4L/day fluid resuscitation and underwent albumin replacement Who Should NOT Join This Trial: - Consent is not given by the patient or his/her guardian, - The initial cause of shock was hypovolemic, cardiogenic or obstructive shock. - Pregnancy or suspected pregnancy - Peripheral limb or severe organ ischemia with peripheral artery disease - Cardiac functions cannot be evaluated optimally by transthoracic echocardiography - Patients who died within the first 24 hours after intensive care admission Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Followed up with a diagnosis of sepsis, * over 18 years old * Patients who were diagnosed with hypo-albuminemia after more than 4L/day fluid resuscitation and underwent albumin replacement Exclusion Criteria: * Consent is not given by the patient or his/her guardian, * The initial cause of shock was hypovolemic, cardiogenic or obstructive shock. * Pregnancy or suspected pregnancy * Peripheral limb or severe organ ischemia with peripheral artery disease * Cardiac functions cannot be evaluated optimally by transthoracic echocardiography * Patients who died within the first 24 hours after intensive care admission

Locations (1)

Samsun University
Samsun, Ilkadım, Turkey (Türkiye)